PORTAGE BIOTECH INC (PRTG)
VGG7185A1286 - Common Stock
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives -Adenosine clinical development paused...
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Company generated approximately $2.8M of non-dilutive funding to extend cash runway...
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update Company focused on adenosine platform clinical development...
Portage Biotech to halt iNKT drug program, cut workforce (NASDAQ:PRTG)
Portage Biotech (PRTG) said that it was halting its iNKT clinical program and would be cutting its workforce in order to focus on its adenosine clinical drug ca
Portage Biotech Reports Business and Strategic Update
Prioritize the adenosine clinical candidates iNKT clinical development paused to focus resourcesCompany will evaluate range of strategic options ...
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update...
Portage Biotech files to sell 9.63M shares for holders (NASDAQ:PRTG)
The financial article discusses Portage Biotech's filing of a prospectus for the resale of 9.63M common shares by selling stockholders.